- Report
- June 2025
- 89 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 89 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 194 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 187 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- June 2025
- 282 Pages
Global
From €5240EUR$5,850USD£4,467GBP
- Report
- April 2025
- 200 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- March 2025
- 175 Pages
Global
From €4022EUR$4,490USD£3,428GBP
- Report
- November 2024
- 338 Pages
Global
From €4478EUR$5,000USD£3,818GBP
- Report
- January 2025
- 182 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- July 2024
- 189 Pages
Global
From €3426EUR$3,825USD£2,920GBP
€4031EUR$4,500USD£3,436GBP
- Report
- May 2025
- 114 Pages
Global
From €4255EUR$4,750USD£3,627GBP
- Drug Pipelines
- April 2025
- 80 Pages
Global
From €1791EUR$2,000USD£1,527GBP
- Report
- December 2024
- 200 Pages
Global
From €3359EUR$3,750USD£2,863GBP
- Report
- November 2022
- 418 Pages
Global
From €2350EUR$2,811USD£2,073GBP
- Report
- May 2024
- 311 Pages
Global
From €5282EUR$6,103USD£4,350GBP
- Report
- December 2023
- 265 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- November 2021
- 201 Pages
Global
From €4434EUR$4,950USD£3,779GBP
- Report
- January 2023
- 131 Pages
Global
From €2239EUR$2,500USD£1,909GBP
- Report
- December 2021
- 296 Pages
Global
From €2351EUR$2,625USD£2,004GBP
€4702EUR$5,250USD£4,009GBP
- Report
- October 2022
- 68 Pages
Global

The Guide RNA (gRNA) market is a subset of the genomics industry that focuses on the development and production of gRNA molecules. gRNA molecules are used in a variety of applications, including gene editing, gene regulation, and gene expression. gRNA molecules are composed of a guide sequence, which is complementary to a specific target sequence in the genome, and a scaffold sequence, which provides stability and specificity to the gRNA molecule.
The gRNA market is driven by the increasing demand for gene editing and gene regulation technologies, as well as the growing need for more efficient and cost-effective gene expression tools. Additionally, the development of new gRNA technologies, such as CRISPR-Cas9, has further increased the demand for gRNA molecules.
Some of the major companies in the gRNA market include Thermo Fisher Scientific, Agilent Technologies, Merck KGaA, New England Biolabs, and OriGene Technologies. Show Less Read more